Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

Rangering i aksjer #3427
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aksjekurs
$30.19
Markedsverdi
$4.98B
Endring (1 dag)
-6.61%
Endring (1 år)
38.21%
Land
IN
Handel Gland Pharma Limited (GLAND)

Kategori

Healthcare
Aksjeprishistorikk for Gland Pharma Limited (GLAND)
Høyeste sluttskurs: $33.16 den 2026-10-01

Laveste sluttskurs: $27.12 den 2020-11-01
Aksjeprishistorikk for Gland Pharma Limited fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 25.92%
2025 -10.12%
2024 -4.91%
2023 8.72%
2022 -58.67%
2021 58.80%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$165.31 23.62%
DE
$40.45 43.11%
JP
$224.81 31.28%
CH
$18.43 -4.03%
IN